Report Detail
Global (United States, European Union and China) Irritable Bowel Syndrome Treatment Market Research Report 2019-2025
- RnM3635655 |
- 30 July, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome is a common disorder. There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in decreasing the symptoms.
Increased awareness about available treatment among the patients, medical community is one of the major driver in global irritable bowel syndrome treatment market.Increase in the number of patients, rise in the aging population, increasing demand for efficiency, increase in the incidence and prevalence of irritable bowel syndrome cases and increase in awareness, the global irritable bowel syndrome market is expected to have a healthy growth rate in the forecast period.
In 2019, the market size of Irritable Bowel Syndrome Treatment is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Irritable Bowel Syndrome Treatment.
This report studies the global market size of Irritable Bowel Syndrome Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Irritable Bowel Syndrome Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Valeant Pharmaceuticals International
Sucampo Pharmaceuticals
Abbott Laboratories
Lexicon Pharmaceuticals
Salix Pharmaceuticals
Ironwood Pharmaceuticals
GlaxoSmithKline
Allergan
Market Segment by Product Type
Irritable Bowel Syndrome with Constipation
Irritable Bowel Syndrome with Diarrhea
Irritable Bowel Syndrome with alternating Constipationand Diarrhea
Market Segment by Application
Hospitals
Clinics
Homecare settings
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Irritable Bowel Syndrome Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Irritable Bowel Syndrome Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Irritable Bowel Syndrome Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Irritable Bowel Syndrome Treatment Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Irritable Bowel Syndrome with Constipation
- 1.3.3 Irritable Bowel Syndrome with Diarrhea
- 1.3.4 Irritable Bowel Syndrome with alternating Constipationand Diarrhea
- 1.4 Market Segment by Application
- 1.4.1 Global Irritable Bowel Syndrome Treatment Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.4.4 Homecare settings
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Irritable Bowel Syndrome Treatment Market Size
- 2.1.1 Global Irritable Bowel Syndrome Treatment Revenue 2014-2025
- 2.1.2 Global Irritable Bowel Syndrome Treatment Sales 2014-2025
- 2.2 Irritable Bowel Syndrome Treatment Growth Rate by Regions
- 2.2.1 Global Irritable Bowel Syndrome Treatment Sales by Regions 2014-2019
- 2.2.2 Global Irritable Bowel Syndrome Treatment Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Irritable Bowel Syndrome Treatment Sales by Manufacturers
- 3.1.1 Irritable Bowel Syndrome Treatment Sales by Manufacturers 2014-2019
- 3.1.2 Irritable Bowel Syndrome Treatment Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Irritable Bowel Syndrome Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Irritable Bowel Syndrome Treatment Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Irritable Bowel Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
- 3.3 Irritable Bowel Syndrome Treatment Price by Manufacturers
- 3.4 Key Manufacturers Irritable Bowel Syndrome Treatment Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Irritable Bowel Syndrome Treatment Market
- 3.6 Key Manufacturers Irritable Bowel Syndrome Treatment Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Irritable Bowel Syndrome with Constipation Sales and Revenue (2014-2019)
- 4.1.2 Irritable Bowel Syndrome with Diarrhea Sales and Revenue (2014-2019)
- 4.1.3 Irritable Bowel Syndrome with alternating Constipationand Diarrhea Sales and Revenue (2014-2019)
- 4.2 Global Irritable Bowel Syndrome Treatment Sales Market Share by Type
- 4.3 Global Irritable Bowel Syndrome Treatment Revenue Market Share by Type
- 4.4 Irritable Bowel Syndrome Treatment Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Irritable Bowel Syndrome Treatment Sales by Application
6 United States
- 6.1 United States Irritable Bowel Syndrome Treatment Breakdown Data by Company
- 6.2 United States Irritable Bowel Syndrome Treatment Breakdown Data by Type
- 6.3 United States Irritable Bowel Syndrome Treatment Breakdown Data by Application
7 European Union
- 7.1 European Union Irritable Bowel Syndrome Treatment Breakdown Data by Company
- 7.2 European Union Irritable Bowel Syndrome Treatment Breakdown Data by Type
- 7.3 European Union Irritable Bowel Syndrome Treatment Breakdown Data by Application
8 China
- 8.1 China Irritable Bowel Syndrome Treatment Breakdown Data by Company
- 8.2 China Irritable Bowel Syndrome Treatment Breakdown Data by Type
- 8.3 China Irritable Bowel Syndrome Treatment Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Irritable Bowel Syndrome Treatment Breakdown Data by Company
- 9.2 Rest of World Irritable Bowel Syndrome Treatment Breakdown Data by Type
- 9.3 Rest of World Irritable Bowel Syndrome Treatment Breakdown Data by Application
- 9.4 Rest of World Irritable Bowel Syndrome Treatment Breakdown Data by Countries
- 9.4.1 Rest of World Irritable Bowel Syndrome Treatment Sales by Countries
- 9.4.2 Rest of World Irritable Bowel Syndrome Treatment Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Valeant Pharmaceuticals International
- 10.1.1 Valeant Pharmaceuticals International Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome Treatment
- 10.1.4 Irritable Bowel Syndrome Treatment Product Introduction
- 10.1.5 Valeant Pharmaceuticals International Recent Development
- 10.2 Sucampo Pharmaceuticals
- 10.2.1 Sucampo Pharmaceuticals Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome Treatment
- 10.2.4 Irritable Bowel Syndrome Treatment Product Introduction
- 10.2.5 Sucampo Pharmaceuticals Recent Development
- 10.3 Abbott Laboratories
- 10.3.1 Abbott Laboratories Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome Treatment
- 10.3.4 Irritable Bowel Syndrome Treatment Product Introduction
- 10.3.5 Abbott Laboratories Recent Development
- 10.4 Lexicon Pharmaceuticals
- 10.4.1 Lexicon Pharmaceuticals Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome Treatment
- 10.4.4 Irritable Bowel Syndrome Treatment Product Introduction
- 10.4.5 Lexicon Pharmaceuticals Recent Development
- 10.5 Salix Pharmaceuticals
- 10.5.1 Salix Pharmaceuticals Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome Treatment
- 10.5.4 Irritable Bowel Syndrome Treatment Product Introduction
- 10.5.5 Salix Pharmaceuticals Recent Development
- 10.6 Ironwood Pharmaceuticals
- 10.6.1 Ironwood Pharmaceuticals Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome Treatment
- 10.6.4 Irritable Bowel Syndrome Treatment Product Introduction
- 10.6.5 Ironwood Pharmaceuticals Recent Development
- 10.7 GlaxoSmithKline
- 10.7.1 GlaxoSmithKline Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome Treatment
- 10.7.4 Irritable Bowel Syndrome Treatment Product Introduction
- 10.7.5 GlaxoSmithKline Recent Development
- 10.8 Allergan
- 10.8.1 Allergan Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Irritable Bowel Syndrome Treatment
- 10.8.4 Irritable Bowel Syndrome Treatment Product Introduction
- 10.8.5 Allergan Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Irritable Bowel Syndrome Treatment Sales Channels
- 11.2.2 Irritable Bowel Syndrome Treatment Distributors
- 11.3 Irritable Bowel Syndrome Treatment Customers
12 Market Forecast
- 12.1 Global Irritable Bowel Syndrome Treatment Sales and Revenue Forecast 2019-2025
- 12.2 Global Irritable Bowel Syndrome Treatment Sales Forecast by Type
- 12.3 Global Irritable Bowel Syndrome Treatment Sales Forecast by Application
- 12.4 Irritable Bowel Syndrome Treatment Forecast by Regions
- 12.4.1 Global Irritable Bowel Syndrome Treatment Sales Forecast by Regions 2019-2025
- 12.4.2 Global Irritable Bowel Syndrome Treatment Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Irritable Bowel Syndrome Treatment. Industry analysis & Market Report on Irritable Bowel Syndrome Treatment is a syndicated market report, published as Global (United States, European Union and China) Irritable Bowel Syndrome Treatment Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Irritable Bowel Syndrome Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
